Kalpana Gupta Shekhawat: A Practical Clinical Approach to Iron Regulation
Kalpana Gupta Shekhawat, Chairperson at the Functional and Metabolic Medicine Academy, Gurugram, India, shared a post on LinkedIn:
“Balancing Ferritin Levels: A Practical Clinical Approach to Iron Regulation
Ferritin is one of the most commonly used markers to assess iron status, yet it is often misinterpreted when evaluated in isolation.
While ferritin reflects iron storage, it is also influenced by inflammation, liver function, metabolic health, and the body’s regulation of iron metabolism.
For this reason, ferritin should always be interpreted in the context of other laboratory markers and the patient’s clinical presentation.
A proper evaluation of iron status typically includes ferritin alongside hemoglobin, mean corpuscular volume (MCV), red cell distribution width (RDW), serum iron, transferrin saturation (TSAT), and inflammatory markers such as C-reactive protein (CRP).
Reviewing these parameters together helps distinguish between true iron deficiency, inflammation-related ferritin elevation, and possible iron overload.
Low ferritin is one of the most reliable indicators of iron deficiency, often seen when levels fall below approximately 30 ng/mL.
However, identifying the underlying cause is essential.
Iron deficiency may result from inadequate dietary intake, chronic blood loss, gastrointestinal infections such as Helicobacter pylori,malabsorption disorders like celiac disease, low gastric acid, or long-term proton pump inhibitor use.
In many cases, impaired absorption rather than low intake is the key contributor.
Management therefore begins with addressing the underlying cause.
When supplementation is required, selecting an appropriate iron preparation, avoiding calcium at the time of dosing, and pairing iron with vitamin C can help improve absorption.
Follow-up testing after six to eight weeks is recommended to monitor response.
Elevated ferritin does not always indicate excess iron.
Because ferritin is an acute-phase reactant, it can increase in conditions such as chronic inflammation, liver dysfunction, infections, and metabolic syndrome.
In such cases, addressing the underlying metabolic or inflammatory drivers is essential.
Ultimately, the clinical goal is not simply raising or lowering ferritin but restoring balanced iron regulation within the body.”
See more in the gallery.
Stay updated with Hemostasis Today.
-
Jun 23, 2026, 18:27Advancing Gene Therapy Research for Glanzmann Thrombasthenia – Glanzmann’s Research Foundation
-
Jun 23, 2026, 18:17What Every ITP Patient Wants to Know – ITP Support Association
-
Jun 23, 2026, 18:13Ahsan Fareed: Exploring Heart Failure Readmissions in Iron Deficiency Anemia
-
Jun 23, 2026, 18:09Swarnava Roy: Key Findings on Stress Erythropoiesis and Mitochondrial Retention in RBCs
-
Jun 23, 2026, 17:40Hossam El Benawi: How do We Predict Recurrence Post LVT Resoultion?
-
Jun 23, 2026, 17:39Nicolas Gendron: Do We Really Need All These Hemostasis Tests in Patients on DOACs?
-
Jun 23, 2026, 17:33Maité Mulkers: Time is Brain, and One Reason is That a Thrombus Develops Over Time
-
Jun 23, 2026, 17:32Dhargam Aljebouri: Honoured to Be Part of the Young Professionals Breakfast at ISBT 2026
-
Jun 23, 2026, 17:27Dianne E. van der Wal: Phenotype and Activation of the Endothelium in ET at ISTH 2026